Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sepragen
AddedFeb 15, 2024
UpdatedJun 18, 2026
Sepragen

Sepragen

Angel

US-based Sepragen offers innovative products and processes for the biotech and nutraceutical sectors.

HQ
Hayward, CA, US
Founded
1985
Overview
Compare
Fundraising
Employees
Website

Sepragen, based in Hayward, United States, is dedicated to providing innovative products and processes for the biotechnology and nutraceutical industries. The company focuses on delivering high-quality columns and related equipment, ranging from 10 liters to 200 liters, designed to enhance efficiency and effectiveness in these sectors. Sepragen's mission is to support their clients through both startup and maintenance phases, ensuring customer success and satisfaction.

Sepragen has earned a reputation for excellent craftsmanship, service, and quality. Their commitment to customer support has been a cornerstone of their operations, as evidenced by positive testimonials from industry professionals. This customer-centric approach has positioned Sepragen as a trusted partner in the biotech and nutraceutical markets, contributing significantly to the advancement of these fields.

Sepragen - Quick Facts

When was Sepragen founded?

Sepragen was founded in 1985.

Where is Sepragen's headquarters located?

Sepragen's headquarters is located in Hayward, CA, US.

When was Sepragen's last funding round?

Sepragen's most recent funding round was for $225k (USD) in June 2017.

How much has Sepragen raised to-date?

As of Jun 21, 2017, Sepragen has raised a total of $475k (USD).

How many employees does Sepragen have?

Sepragen has 31 employees as of Feb 5, 2024.

Sepragen - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Columns
  • Equipment
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3824Totalizing Fluid Meters And Counting Devices
ISIC
  • 2310Manufacture of glass and glass products
Show 16 more industry codes
NAICS
  • 327000Nonmetallic Mineral Product Manufacturing
  • 327200Glass and Glass Product Manufacturing
  • 327210Glass and Glass Product Manufacturing
  • 327215Glass Product Manufacturing Made of Purchased Glass
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334514Totalizing Fluid Meter and Counting Device Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3200Stone, Clay, Glass, And Concrete Products
  • 3230Glass Products, Made Of Purchased Glass
  • 3231Glass Products, Made of Purchased Glass
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 2830Drugs
  • 2834Pharmaceutical Preparations